KBC Securities - ONWARD MEDICAL NV (ONWD) Morning Notes : ONWD BB

Report

KBC Securities

Jacob Mekhael

Morning Notes : ONWD BB

: ONWD BB

19/08/2025 1 EN

Underlying

ONWARD MEDICAL NV

See profile

NL0015000HT4 Euronext Brussels Netherlands

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Jacob Mekhael

Other Reports on these Companies

KBC Securities

Life Sciences Conference 25 Sep 2025

KBC Securities will host its annual life sciences conference on 25 September in Brussels. The event will include 14 exciting companies, both public and private, from the BeNeLux ecosystem and beyond. In this conference note, we provide an overview of the attending companies, as well as an outlook on KBC Securities' life sciences broader coverage.

September 24, 2025 September 24, 2025 1 EN

KBC Securities

Onward Medical Publishes ARCIM data on blood pressure regulation in Nature Medicine

Onward announced two publications of detailed results from the clinical feasibility studies of ARC-IM therapy in blood pressure regulation in Nature and Nature Medicine. The publications build on the previously reported interim results, and continue to highlight the benefit of the ARC-IM system for SCI patients that have blood pressure instability. Note that ARC-IM for blood pressure instability is the next in line indication for Onward, where a pivotal (Empower BP) study is due to start by YE25, with an interim analysis planned for 2H26, and could lead to an accelerated path to market. We rei...

September 18, 2025 September 18, 2025 1 EN

KBC Securities

Morning Notes : NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

: NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

September 18, 2025 September 18, 2025 1 EN

Morning Notes : GLPG NA, GBLB BB, PROX BB, TUB BB, DEME BB

: GLPG NA, GBLB BB, PROX BB, TUB BB, DEME BB

October 3, 2025 October 3, 2025 1 EN

Jacob Mekhael

Jacob Mekhael

Galapagos Media reports Paul Stoffels behind non-binding offer for cell therapy unit

According to media reports, Paul Stoffels, Galapagos' previous CEO, has assembled a group of investors to bid for the company's cell therapy business. After joining Galapagos in 2022, Paul Stoffels pivoted the company towards cell therapies and focussed the company's efforts on de-centralised CAR-T manufacturing as a way to broaden access to such treatments. Following his resignation earlier this year, he now has placed a non-binding offer for the cell therapy business which is under strategic review. Financing for a potential deal has not yet been finalised, and binding offers are expected in...

October 3, 2025 October 3, 2025 1 EN

Wim Hoste

Wim Hoste

Titan Titan & Molins complete joint acquisition of majority stake in Baupartner

Following the initial announcement on August 4th, Molins and Titan have now successfully closed the joint acquisition of an 80% stake in Baupartner, a leading provider of precast concrete solutions in Southeastern Europe. The transaction closed in line with previously communicated expectations, with the companies having guided for completion by the end of Q3 2025. Strategically, the acquisition aligns with Titan's current regional presence. Titan also mentioned that it is are actively evaluating further opportunities to grow the precast concrete solutions in the region. we reiterate our Accum...

October 2, 2025 October 2, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : ONWD BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Life Sciences Conference 25 Sep 2025

Onward Medical Publishes ARCIM data on blood pressure regulation in Nature Medicine

Morning Notes : NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

Morning Notes : GLPG NA, GBLB BB, PROX BB, TUB BB, DEME BB

Galapagos Media reports Paul Stoffels behind non-binding offer for cell therapy unit

Titan Titan & Molins complete joint acquisition of majority stake in Baupartner

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe